Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.

To examine the influence of intravenous steroid-treatment (IST) on serum levels of Cartilage oligomeric matrix protein (COMP) in patients with active rheumatoid arthritis (RA). Serum levels of COMP and C-reactive protein (CRP) were measured in 12 patients with highly active RA (Steinbrocker stages II-IV) and in 5 patients with highly active reactive arthritis (ReA) (positive testing for HLA-B27) before starting daily IST. Patients received a total steroid dosage between 100 and 500 mg of prednisolone. COMP was measured by a commercially available sandwich-type ELISA-kit developed by AnaMar Medical AB, Sweden. Statistical evaluation was calculated by paired t test. In the RA group, COMP levels ranged from 6.3 to 19.4 U/l (mean 12.9 U/l), CRP from 5 to 195 mg/l (mean 77.8 mg/l), the COMP levels of the ReA group ranged from 5.1 to 7.4 U/l (mean 7.9 U/l), the CRP levels from 13 to 126 mg/l (mean 49 mg/l). We found a significant difference between the initial COMP levels in RA+ and ReA patients (P<0.005). In contrast to the ReA group, serum-COMP levels of RA+ patients (P<0.004) and the VAS (P<0.0001) decreased significantly within 2-10 days after the first treatment with steroids. The CRP levels remained unchanged in both groups. Our results indicate that the intravenous treatment with steroids in patients with highly active RA leads to a significant decrease of cartilage degradation. COMP seems to be a valuable parameter not even as a prognostic factor, but as a marker for monitoring the therapy response in patients with RA.

The effect of balneotherapy on ambulatory blood pressure.

CONTEXT: Balneotherapy, a treatment that includes carbon dioxide and mud baths as well as massages and physical therapy, is successfully used in the treatment of rheumatic pain and other disorders such as cardiovascular and gynecological disease. OBJECTIVE: To study the effect of a 3-week treatment of balneotherapy on 24-hour ambulatory blood pressure in 35 patients. DESIGN: Balneotherapeutic applications were applied between 2 and 5 times a week and had a duration of 20 minutes. The mean 24-hour blood pressure, daytime blood pressure (7 AM to 10 PM), nighttime blood pressure (10 PM to 6 AM), nighttime dipping, and 24-hour blood pressure variability were measured. The effect of balneotherapy was evaluated using analysis of variance. In addition, the circadian variation of blood pressure was calculated using a cosinor analysis. SETTING: The Austrian spa resort Bad Tatzmannsdorf. PARTICIPANTS: 35 balneotherapy patients (15 men, 20 women). INTERVENTION: Balneotherapy. MAIN OUTCOME MEASURES: 24-hour ambulatory blood pressure was measured with an ambulatory monitor using an oscillometric method. RESULTS: The results indicated that the 24-hour blood pressure and day- and nighttime blood pressure of patients with medium and high initial values decreased significantly (P < .05) after 3 weeks of balneotherapy, whereas patients with low blood pressure showed almost no change. The 24-hour blood pressure variation pattern of patients with medium values remained nearly unchanged during the balneotherapy. In contrast, a clear improvement in the circadian variation variables of patients with high initial blood pressure could be detected at the end of balneotherapy. CONCLUSION: Patients with medium and, especially, higher initial blood pressure values seem to benefit from balneotherapy.

[Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A]. / Serumspiegel löslicher CD44-Isoform-Variante 5 von Patienten mit seropositiver Rheumatoid-Arthritis unter Cyclosporin-A-Therapie.

CD44 is a widely expressed cell surface glycoprotein which is involved in many cell-cell and cell-matrix interactions. Expression of soluble CD44 splice variants is strictly regulated and is linked to a high rate of cell division. Serum levels of soluble CD44 variant 5 (sCD44v5) were determined in 14 patients with erosive RA. Patients were divided into two groups. In group 1 cyclosporin A treatment (CYA) was initiated after the first visit. In group 2 preliminary CYA was continued. Controls were performed after 6 months. We found a significant decrease of swollen joint count (SJC) and sCD44v5 in group 1. No effect of CYA was found on c-reactive protein, erythrocyte sedimentation rate and IgM-rheumatoid factor (IgM-RF). In group 2 a significant decrease of CRP was found. Therefore we conclude that measurement of sCD44v5 might be useful in monitoring RA+ patients with CYA.

Calcium, magnesium, copper and zinc content of menu components: comparison of analysed with calculated values.

The objective of this study was to show whether analysed nutrient data correlate with calculated values from a food database. For this purpose the calcium, magnesium, copper and zinc contents of 62 menu components from lunch menus were determined with ICP-AES. Then the analysed values were compared with calculated values from a widely used food database. Our results indicated that there is a significant correlation (p < 0.01) between the analysed and calculated values of all four elements. The correlation coefficient as determined with nonparametric correlation analysis was 0.807 for calcium, 0.786 for magnesium, 0.772 for zinc, and 0.414 for copper. Although these correlations are significant, great differences between analysed and calculated values for all four elements could be found when considering single menu components. Therefore data of studies illustrating analysed with calculated values of single menu components have practical importance.

[IgA rheumatoid factor and prognosis in chronic polyarthritis]. / IgA-Rheumafaktor und Prognose der chronischen Polyarthritis.

We determined the prognostic value of IgA rheumatoid factor in patients with rheumatoid arthritis. The results show clearly that only patients with high titers of IgARF during their course had an unfavorable prognosis determined by functional status and mortality.

Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells.

The objective of the present study was to examine whether cinnamic acid exerts antitumor activity against colon cancer cells in vitro. For this purpose we investigated the effect of cinnamic acid on cell proliferation and on the differentiation markers alkaline phosphatase, sucrase and aminopeptidase N in human colon adenocarcinoma cells (Caco-2). Cinnamic acid (2.5-8.0 mM) prolonged the doubling time and inhibited the DNA synthesis of growing cells. The antiproliferative effect occurred rapidly after 2 h of treatment with 8.0 mM cinnamic acid and reached nearly maximal values after 8 h of treatment. Sucrase and aminopeptidase N activities were stimulated under cinnamic acid treatment (4.0-8.0 mM), while alkaline phosphatase activity was inhibited in postconfluent cells (8.0 mM). Similar effects on enzyme activities were seen in non-proliferating cells. Cinnamic acid did not alter the adhesion to collagen matrix or cell viability. Intracellular cAMP levels were decreased significantly after 1 h of treatment with 8.0 mM cinnamic acid, suggesting that cinnamic acid induces its effects on enzyme activities partly by modulating the cAMP signaling pathway.

A ferric reductase activity is found in brush border membrane vesicles isolated from Caco-2 cells.

Brush border membrane vesicles isolated from Caco-2 cells were used to examine whether there is an apical membrane-associated ferric reductase activity in small intestinal enterocytes. A ferric reductase activity which was dependent on NADH or NADPH as reductants was shown. Reduction of Fe(III) was quantified by the formation of a stable Fe(II)/ferrozine complex. The ferric reductase revealed saturation kinetics with a K(m) of 4.12 +/- 0.65 micromol/L and a Vmax of 3.11 +/- 0.043 nmol/(min.mg protein) for NADH. About 25% of the electrons for the NADH-dependent ferric iron reduction were transferred indirectly from the superoxide anion as verified by the superoxide dismutase inhibitable ferric iron reduction rate. However, the main part of Fe(III) reduction occurs directly by catalyzed electron transfer from NADH to ferric iron through (an) enzyme(s) located in the brush border membrane. The ferric reductase activity was inhibited by Pt(II) and especially p-chloromercuribenzoate. Ferricyanide, which is also reduced by the enzyme, is a competitive inhibitor of the Fe(III)/nitrilotriacetate (NTA) complex with a Ki of 43 micromol/L. These results suggest that brush border membranes of enterocytes possess a ferric reductase that reduces ferric to ferrous iron before the iron is transported through the microvillous membrane.